Leyden Labs
Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families. The Leyden Labs’ energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.
Growth Trajectory
Leyden Labs is expanding rapidly, indicated by their active recruitment, presence in Singapore, and recent funding rounds, suggesting a strong growth trajectory. Their product development plans include advancing intranasal antibody programs and expanding the product line beyond PanFlu™ to target other respiratory viruses. The company seeks collaborations with academics, commercial researchers, and investors to further develop their business and prepare for future pandemics.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats